James A. Carson
Muscle physiologist studying cancer-associated cachexia and how chemotherapy and exercise remodel skeletal-muscle metabolism
Professor, Department of Kinesiology & Sport Management, and Executive Director, Huffines Institute for Sports Medicine & Human Performance, Texas A&M University (since 2024) · formerly Senior Associate Dean for Research and Graduate Studies, College of Health Professions, University of Tennessee Health Science Center (2018–2024) · 19 years on faculty at the University of South Carolina, where he built its muscle-biology research program and directed its Exercise Science PhD program
Integrative Muscle Biology Laboratory, Texas A&M University (College Station, Texas, USA) ↗ Lab lineage1 direct trainee → ORCID0000-0003-3733-8796 ↗
Carson leads the Integrative Muscle Biology Laboratory and is among the field's established voices on cancer-associated cachexia — the muscle wasting that accompanies tumours and their treatment. He moved the laboratory to Texas A&M University in 2024, after six years at the University of Tennessee Health Science Center (2018–2024) and, before that, 19 years at the University of South Carolina building a muscle-biology research program and its Exercise Science doctoral program.
His laboratory combines in vivo and in vitro models to examine how mechanical, inflammatory and hormonal signals converge on skeletal-muscle anabolic and metabolic plasticity. The 2026 study he senior-authored asked a narrower version of that question: whether the muscle damage caused by FOLFOX chemotherapy runs through mTORC1 and AMPK's control of autophagy, and whether rapamycin — by restoring autophagy flux — could partly undo it.
Milestones in the Atlas
A selection, not a full bibliography: only papers that meet the Atlas inclusion criteria.
| Year | Evidence | Study |
|---|---|---|
| 2026 | M | 5-Fluorouracil-based chemotherapy disrupts autophagy flux and protein synthesis in cultured myotubes: a role for mTORC1 signaling HAL2026 Senior and corresponding author; his laboratory's long-standing work on cancer-associated cachexia framed the study's focus on chemotherapy-induced disruption of muscle mTORC1/AMPK signalling. |
Co-authors in the Atlas 1
People with a profile here who share at least one study with James A. Carson.
ShowHide
- Jessica L. Halle Muscle-biology researcher studying how cancer, chemotherapy and cachexia disrupt skeletal-muscle protein turnover and autophagy
Every researcher with a profile →
Thank you. That helps us know which pages have been read by someone who knows the work.
Thank you. We will check it and correct the page.
Thank you. Your answer was counted anonymously.